recent articles
New paradigms for quantitative assessment of PD-1 and PD-L1 using t...
- Artificial Intelligence
- Clinical Laboratories
- Clinical Pathology
- Data Management
- Device Manufacturers
- Digital Pathology News
- File format
- Genetics
- Image Analysis
- Informatics
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- New Digital Imaging Technologies
- Pathology News
- Vendor products
- Whole slide
Indica Labs, Inc announced recently that the HALO® platform was used in two recent research papers that describe novel digital image analysis protocols for PD-1 and PD-L1 quantification and may help to identify potential responders to...
25 years ago when I started my clinical rotations as a third-year medical student, my interest in pathology across the medical and surgical specialties was usually met with a question such as "Why do you want to do pathology? You are going to...
Case Study using HALO™ and STRATA™: Biomarkers of Anti-Tumor Immune...
- Anatomic Pathology
- Clinical Laboratories
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- General Healthcare News
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Marketing
- Medical Research
- Pathology News
- Science
- Vendor products
- Web/Tech
- Webinars
- Whole slide
Wednesday September 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive. ...
New Mexico, USA 12/2/2014 - Indica Labs announced today that its HALO™ image analysis platform was used to quantify predictive biomarkers in a ground breaking study of the melanoma drug, pembrolizumab. Pembrolizumab is an immunotherapy...